Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Elevation Oncology, Inc. (ELEV)

Compare
0.2475
-0.0116
(-4.48%)
At close: April 1 at 4:00:00 PM EDT
0.2451
-0.00
(-0.97%)
After hours: April 1 at 7:51:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
44,703
44,703
40,338
94,549
32,046
Operating Income
-44,703
-44,703
-40,338
-94,549
-32,046
Net Non Operating Interest Income Expense
1,203
1,203
-229
-500
--
Other Income Expense
-942
-942
-5,107
-6
7
Pretax Income
-44,442
-44,442
-45,674
-95,055
-32,039
Tax Provision
43
43
30
25
--
Net Income Common Stockholders
-44,485
-44,485
-45,704
-95,080
-32,039
Diluted NI Available to Com Stockholders
-44,485
-44,485
-45,704
-95,080
-32,039
Basic EPS
-0.78
--
-1.25
-4.09
-2.64
Diluted EPS
-0.78
--
-1.25
-4.09
-2.64
Basic Average Shares
57,275.4540
--
36,522.7160
23,267.1200
12,132.6100
Diluted Average Shares
57,275.4540
--
36,522.7160
23,267.1200
12,132.6100
Total Operating Income as Reported
-44,703
-44,703
-45,445
-94,549
-32,046
Total Expenses
44,703
44,703
40,338
94,549
32,046
Net Income from Continuing & Discontinued Operation
-44,485
-44,485
-45,704
-95,080
-32,039
Normalized Income
-43,740.8200
-43,740.8200
-41,669.4700
-95,080
-32,039
Interest Income
5,203
5,203
3,971
1,000
--
Interest Expense
4,000
4,000
4,200
1,500
--
Net Interest Income
1,203
1,203
-229
-500
--
EBIT
-40,442
-40,442
-41,474
-93,555
-32,046
EBITDA
-40,418
-40,418
-41,435
-93,528
-32,028
Reconciled Depreciation
24
24
39
27
18
Net Income from Continuing Operation Net Minority Interest
-44,485
-44,485
-45,704
-95,080
-32,039
Total Unusual Items Excluding Goodwill
-942
-942
-5,107
--
--
Total Unusual Items
-942
-942
-5,107
--
--
Normalized EBITDA
-39,476
-39,476
-36,328
-93,528
-32,028
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
--
Tax Effect of Unusual Items
-197.8200
-197.8200
-1,072.4700
--
--
12/31/2021 - 6/25/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CTMX CytomX Therapeutics, Inc.
0.5800
-8.78%
 
CGTX Cognition Therapeutics, Inc.
0.3921
-6.82%
 
MRSN Mersana Therapeutics, Inc.
0.3343
-2.88%
 
INAB IN8bio, Inc.
0.1727
+4.04%
 
IPSC Century Therapeutics, Inc.
0.4518
-5.08%
 
CNTX Context Therapeutics Inc.
0.5511
-9.95%
 
GOSS Gossamer Bio, Inc.
0.9943
-9.61%
 
UNCY Unicycive Therapeutics, Inc.
0.5460
-5.03%
 
VOR Vor Biopharma Inc.
0.6200
-13.59%
 
VINC Vincerx Pharma, Inc.
0.5750
+8.61%